Last edition
News about Global Pharma
Kwality Pharma Receives Registration for Anti-Cancer Drug Bleomycin 15 IU In Mexico
Kwality Pharmaceuticals has received product registration for Bleomycin 15 IU in Mexico for sale and distribution, expanding its oncology portfolio in regulated markets
Global Pharma | 18/08/2025 | By Dineshwori | 197
UK Approves Sanofi's Teplizumab to Delay Onset of Stage 3 Type 1 Diabetes
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved teplizumab (Tzield) to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and children aged 8 years and older with Stage 2 T1D.
Global Pharma | 18/08/2025 | By Dineshwori | 244
Tonix Pharmaceuticals Secures FDA Nod for Tonmya, a First-in-Class Therapy for Fibromyalgia
Tonix Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for Tonmya (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults.
Global Pharma | 18/08/2025 | By Dineshwori | 369
Alembic Secures Final USFDA Nod for Tretinoin Cream USP, 0.025%
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Tretinoin Cream USP, 0.025 percent, indicated for the treatment of acne vulgaris.
Global Pharma | 16/08/2025 | By Dineshwori | 558
Novo Nordisk's Wegovy Approved for Treatment of MASH in Adults with Liver Fibrosis
The US FDA has approved an additional indication for Wegovy (semaglutide 2.4 mg) for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis, according to Novo Nordisk.
Global Pharma | 16/08/2025 | By Dineshwori | 359
US-based biopharmaceutical company Precigen has received approval from the Food and Drug Administration (FDA) for its immunotherapy PAPZIMEOS (zopapogene imadenovec-drba) for the treatment of adults with recurrent respiratory papillomatosis (RRP).
Global Pharma | 16/08/2025 | By Dineshwori | 196
Vcare, Huadong Medicine Join Forces to Commercialise JAK1 Inhibitor VC005 Tablets in China
Jiangsu Vcare Pharmatech has entered an exclusive strategic partnership with Huadong Medicine to commercialize its innovative JAK1 inhibitor VC005 tablets for autoimmune diseases in China.
Global Pharma | 16/08/2025 | By Mrinmoy Dey | 368
Shilpa Medicare Secures CDSCO Approval for NorUDCA Tablets in NAFLD Treatment
Shilpa Medicare Ltd has received approval from India's Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD).
Global Pharma | 16/08/2025 | By Dineshwori | 551
Superluminal and Eli Lilly Partner on Next-Gen Cardiometabolic and Obesity Treatments
Superluminal Medicines has announced a collaboration with Eli Lilly and Company to advance small molecule therapeutics for cardiometabolic diseases and obesity.
Global Pharma | 16/08/2025 | By Dineshwori | 221
Trump Directs HHS to Fill Strategic API Reserve to Bolster Pharma Supply Chain
US President Donald Trump has signed an executive order to strengthen the American pharmaceutical supply chain resilience by filling the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR).
Global Pharma | 14/08/2025 | By Dineshwori | 305
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy